Universal preoperative SARS-CoV-2 testing can facilitate safe surgical treatment during local COVID-19 surges | Zendy

Anai N. Kothari | Zendy; A T Trans | Zendy; Abigail S. Caudle | Zendy; Mark W. Clemens | Zendy; Matthew H. G. Katz | Zendy; Scott E. Woodman | Zendy; George J. Chang | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Universal preoperative SARS-CoV-2 testing can facilitate safe surgical treatment during local COVID-19 surges

Author(s) -

Anai N. Kothari,

A T Trans,

Abigail S. Caudle,

Mark W. Clemens,

Matthew H. G. Katz,

Scott E. Woodman,

George J. Chang

Publication year - 2020

Publication title -

british journal of surgery

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.202

H-Index - 201

eISSN - 1365-2168

pISSN - 0007-1323

DOI - 10.1093/bjs/znaa062

Subject(s) - medicine , asymptomatic , covid-19 , coronavirus , surgery , virology , disease , outbreak , infectious disease (medical specialty)

This research letter details the experience of a large cancer center's experience with a universal asymptomatic preoperative SARS-CoV-2 testing program that facilitated safe surgical treatment during a local surge of coronavirus cases. A total of 5,234 asymptomatic tests were performed with a test positivity rate that correlated with the increase in community prevalence of COVID-19 infections. No patients developed a postoperative SARS-CoV-2 infection with no documented patient-to-patient or patient-to-provider spread.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research